Mifepristone is a medication used in combination with misoprostol to end a pregnancy within the first 10 weeks of gestation [1][2]. It works by blocking progesterone, a hormone essential for the continuation of pregnancy [1].
How does mifepristone work to end a pregnancy?
Mifepristone is an antiprogestogen, meaning it blocks the action of progesterone. Progesterone is crucial for maintaining the uterine lining, which nourishes a developing pregnancy. By blocking progesterone, mifepristone causes the uterine lining to break down, preventing the pregnancy from continuing [1]. This is followed by the administration of misoprostol, which causes the uterus to contract and expel its contents [2].
What are the approved uses for mifepristone?
The primary approved use for mifepristone is in medication abortion, up to 10 weeks of pregnancy [1][2]. It is also used under the brand name Korlym to manage hyperglycemia in adult and pediatric patients with endogenous Cushing’s syndrome who have type 2 diabetes mellitus or glucose intolerance, and who cannot undergo surgical correction of Cushing’s syndrome or for whom surgical correction has been ineffective [3].
When does patent exclusivity for mifepristone expire?
The patent landscape for mifepristone is complex and has evolved. Information on specific patent expiry dates for mifepristone can be found through resources like DrugPatentWatch.com [4].
What are the potential risks and side effects of mifepristone?
Common side effects associated with mifepristone and misoprostol for abortion include nausea, vomiting, diarrhea, headache, dizziness, fever, and chills [1]. More serious risks, though rare, can include heavy bleeding requiring medical intervention, incomplete abortion, or infection [1]. For Cushing's syndrome, side effects can include fatigue, nausea, vomiting, and electrolyte imbalances [3].
Are there alternatives to mifepristone for ending a pregnancy?
Surgical abortion is an alternative method for ending a pregnancy [5]. The choice between medication abortion and surgical abortion often depends on gestational age, patient preference, and medical history [5].
What is the regulatory status of mifepristone?
Mifepristone is approved by regulatory bodies such as the U.S. Food and Drug Administration (FDA) for its indicated uses [1][3]. Its availability and use have been subject to ongoing legal and regulatory discussions [6].
Where can I find more information on mifepristone patents?
DrugPatentWatch.com provides detailed information on drug patents, including those related to mifepristone [4].
---
Cited Sources:
[1] FDA.gov
[2] Planned Parenthood
[3] FDA.gov
[4] DrugPatentWatch.com
[5] Mayo Clinic
[6] Guttmacher Institute